Back to Search
GEORGE MAREK, MD, PHD
MD, PHD
Gastroenterology Physician
NPI: 1578023537IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
71133(MN)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Class of 2019
Research & Publications (20)
Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.
PMID 19324062·Neuropharmacology·2009
7-preclinical
The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.
PMID 18772320·J Pharmacol Exp Ther·2008
7-preclinical
Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex.
PMID 18621097·Neurosci Lett·2008
7-preclinical
Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration.
PMID 18486339·Neurosci Lett·2008
7-preclinical
Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.
PMID 18294819·Eur Neuropsychopharmacol·2008
7-preclinical
AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes.
PMID 17728034·Prog Neuropsychopharmacol Biol Psychiatry·2008
7-preclinical
Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
PMID 17204749·J Pharmacol Exp Ther·2007
4-observational
Metabotropic glutamate receptors in the control of mood disorders.
PMID 17430147·CNS Neurol Disord Drug Targets·2007
6-review
Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
PMID 17349861·Int Rev Neurobiol·2007
6-review
Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
PMID 17224717·J Clin Psychopharmacol·2007
3-trial
Group III metabotropic glutamate receptor agonists selectively suppress excitatory synaptic currents in the rat prefrontal cortex induced by 5-hydroxytryptamine2A receptor activation.
PMID 17021259·J Pharmacol Exp Ther·2007
7-preclinical
The mGlu2/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression.
PMID 16469447·Neurosci Lett·2006
7-preclinical
Markers of pulmonary hypertension in potential candidates to heart transplantation.
PMID 17642136·Przegl Lek·2006
3-trial
Allogenic heart valve bank in the Department of Cardiovascular Surgery and Transplantology of Jagiellonian University in Cracow - 23 years experience in the treatment of aortic valve or aortic root diseases.
PMID 16933039·Cell Tissue Bank·2006
8-other
5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740.
PMID 16759803·Neurosci Lett·2006
7-preclinical
A pilot study to derive clinical variables for selective chest radiography in blunt trauma patients.
PMID 16631976·Ann Emerg Med·2006
3-trial
Developing therapeutics for schizophrenia and other psychotic disorders.
PMID 16489367·NeuroRx·2005
6-review
The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
PMID 15886717·Neuropsychopharmacology·2005
7-preclinical
Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
PMID 15893376·Neurosci Biobehav Rev·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1600 SW ARCHER RD STE 4102
GAINESVILLE, FL 32610 - Phone
- (352) 265-0239
Quick Facts
- NPI
- 1578023537
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile